These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30311397)

  • 1. Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry.
    Wańha W; Mielczarek M; Smolka G; Roleder T; Jaguszewski M; Ciećwierz D; Tomasiewicz B; Kubler P; Gorol J; Chmielecki M; Bartuś S; Navarese EP; Kasprzak M; Sukiennik A; Kubica J; Lekston A; Hawranek M; Reczuch K; Gruchała M; Ochała A; Wojakowski W
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):574-582. PubMed ID: 30311397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE study.
    Cortese B; Montefusco A; D'Ascenzo F; La Manna A; Andò G; Bisceglia T; Secco GG; Meyer-Gessner M; Wańha W; Sganzerla P; Napodano M; Di Palma G; Latini RA; Tamburino C; Orrego PS; Baumbach A
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):831-836. PubMed ID: 29661597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
    Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT
    EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions.
    Vlieger S; Simsek C; Balland A; Somi S; Jessurun G; Amoroso G; Kauer F; van Geuns RJ; IJsselmuiden A
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):966-971. PubMed ID: 30903739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.
    Montefusco A; De Filippo O; Gili S; Mancone M; Calcagno S; Cirillo P; Esposito G; Poli A; Ferrara E; Smolka G; Wanha W; Palmieri C; Pastormerlo LE; Baumbach A; Sganzerla P; Tamburino C; Bruno F; Secco GG; Nicolino A; Yew KL; di Palma G; Wojakowski W; Sardella G; Rinaldi M; Cortese B; D'Ascenzo F
    Coron Artery Dis; 2020 Jan; 31(1):27-34. PubMed ID: 31658146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.
    Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT
    EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry.
    Magro M; Girasis C; Bartorelli AL; Tarantini G; Russo F; Trabattoni D; D'Amico G; Galli M; Gómez Juame A; de Sousa Almeida M; Simsek C; Foley D; Sonck J; Lesiak M; Kayaert P; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Mar; 8(11):1259-69. PubMed ID: 23538155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First human trial of KW39 slotted-tube stents: for percutaneous coronary intervention.
    Tanaka M; Tsuno NH; Mitsudo K; Kadota K; Tatami R; Kato M; Kato K; Nogami A; Ishikawa O; Takahashi K
    Tex Heart Inst J; 2011; 38(5):502-7. PubMed ID: 22163123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.
    Lee MS; Jurewitz D; Zimmer R; Pessegueiro A; Bhatia R; Currier J; Yeatman L; Tobis JM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):909-14. PubMed ID: 19016467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE experience (the RUDI registry).
    Sardella G; Conti G; Bisceglia T; Canali E; Mancone M; De Carlo C; Spedicato L; Morocutti G; Fedele F; Bernardi G
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1068-75. PubMed ID: 21567883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.
    Gaede L; Liebetrau C; Dörr O; Blumenstein J; Elsässer A; Hamm CW; Möllmann H; Schlundt C; Nef HM; Achenbach S
    Coron Artery Dis; 2017 Nov; 28(7):588-596. PubMed ID: 28704242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
    Grundeken MJ; Lu H; Vos N; IJsselmuiden A; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; de Winter RJ; Wykrzykowska JJ; Amoroso G; Koch KT
    J Invasive Cardiol; 2017 Aug; 29(8):253-258. PubMed ID: 28756418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
    Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
    Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.